A Fatal Case of Suicide Fruit Ingestion in Singapore by Cerbera Cardiac Glycoside Intoxication: Case Report and Review of Literature

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 172

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_PJMT-9-3_007

تاریخ نمایه سازی: 19 بهمن 1399

Abstract:

Case Presentation: We present a case of Cerbera fruit ingestion which highlight the knowledge gap in unusual glycoside poisoning. Despite the patient’s asymptomatic presentation, life threatening clinical features such as hyperkalaemia, hypotension and arrhythmia occurred later. Treatments instituted were activated charcoal (AC), atropine, hyperkalaemia management, Digoxin Fab and intravenous lipid emulsion (ILE). Advanced Cardiac Life Support (ACLS) was instituted with automated chest compression device. The patient died despite prolonged of resuscitation effort. Cerbera glycoside toxicity warrants serious consideration in view of rare presentation and unpredictable nature of toxicology. Discussion: We highlight the prevalence of Cerbera species in Asia-Pacific and present the similarities of cardiac glycosides pharmacology. Early recognition of ingestion and cardiac monitoring are particularly important. In this case, we highlight the diagnostic and prognostic challenge as patient deteriorated despite normal serum digoxin level. As the evidence of Cerbera glycoside poisoning treatment options is lacking, we take this opportunity to examine treatment options assuming similar pharmacology among cardiac glycoside family. We argue for a case for use of Digoxin Fab which is the prevailing treatment for glycoside poisoning. Multi-dose-activated charcoal (MDAC) and ILE are postulated to have physiological basis given current evidence. Electrical and pharmacology treatment for arrhythmia were explored as there is limited evidence. We propose ECMO should always be considered for cardiac toxicity in anticipation of treatment failure as the novel therapy has shown great promise. Conclusion: Cerbera glycoside poisoning should be treated with utmost caution as the fruit is easily accessible and highly toxic. Close cardiac monitoring is a must due to high mortality risk. Digoxin Fab should be instituted as guided by toxicologist. Patients should be transferred to ECMO centre for observation in all cases due to the unpredictable nature of toxin. Further investigation of treatment is awaited.

Authors

- -

Juronghealth Campus - Ng Teng Fong General Hospital, National University Health System

- -

Department of Intensive Care Medicine, Ng Teng Fong General Hospital, National University Health System, Singapore

- -

Department of Intensive Care Medicine, Juronghealth Campus, National University Health System, Singapore.

- -

Division Director, Analytical Toxicology Division, Applied Science Group, Health Sciences Authority (HSA) Singapore

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • 1.Gaillard Y, Krishnamoorthy A, Bevalot F. Cerbera odollam: a “suicide ...
  • 2. Cerbera odollam. Available from: https://lkcnhm.nus.edu.sg/dna/organisms/details/302 Accessed August 11, 2019 ...
  • 3. Flora Fauna Web. [cited 2019 Nov 12]. Available from: ...
  • 4. Menezes RG, Usman MS, Hussain SA, Madadin M, Siddiqi ...
  • 5. Severson E, Jufer-Phipps R, Fowler DR, Alexander R. Beyond ...
  • 6. Kassop D, Donovan MS, Cohee BM, Mabe DL, Wedam ...
  • 7. Eddleston M, Haggalla S. Fatal injury in eastern Sri ...
  • 8. Carlier J, Guitton J, Bévalot F, Fanton L, Gaillard ...
  • 9. Cheenpracha S, Karalai C, Rat-A-Pa Y, Ponglimanont C, Chantrapromma ...
  • 10. Prassas I, Diamandis EP. Novel therapeutic applications of cardiac ...
  • 11. Nelson LS, Hoffman RS, Howland MA, Lewin NA, Goldfrank ...
  • 12. Wermuth ME, Vohra R, Bowman N, Furbee RB, Rusyniak ...
  • 13. Menon MS, Kumar P, Jayachandran CI. Clinical Profile and ...
  • 14. Roberts DM, Gallapatthy G, Dunuwille A, Chan BS. Pharmacological ...
  • 15. Khajja BS, Sharma M, Singh R. Forensic Study of ...
  • 16. Radford DJ, Cheung K, Urech R, Gollogly JR, Duffy ...
  • 17. Laphookhieo S, Cheenpracha S, Karalai C, Chantrapromma S, Rat-a-Pa ...
  • 18. Maillaud C, Lefebvre S, Sebat C, Barguil Y, Cabalion ...
  • 19. Laizure SC, Herring V, Hu Z, Witbrodt K, Parker ...
  • 20. Renymol B, Palappallil D, Ambili N. Study on clinical ...
  • 21. Bismuth C, Gaultier M, Conso F, Efthymiou ML. Hyperkalemia ...
  • 22. Antman EM, Wenger TL, Butler VP Jr, Haber E, ...
  • 23. Woolf AD, Wenger T, Smith TW, Lovejoy FH Jr. ...
  • 24. Roberts DM, Buckley NA. Antidotes for acute cardenolide (cardiac ...
  • 25. Rajapakse S. Management of yellow oleander poisoning. Clin Toxicol. ...
  • 26. Cheung K, Urech R, Taylor L, Duffy P, Radford ...
  • 27. Roberts DM, Southcott E, Potter JM, Roberts MS, Eddleston ...
  • 28. Lip GY, Metcalfe MJ, Dunn FG. Diagnosis and treatment ...
  • 29. de Silva HA, Fonseka MMD, Pathmeswaran A. Multiple-dose activated ...
  • 30. American Academy of Clinical Toxicology, European Association of Poisons ...
  • 31. Eddleston M, Juszczak E, Buckley NA, et al. Multiple-dose ...
  • 32. Dasgupta A, Emerson L. Neutralization of cardiac toxins oleandrin, ...
  • 33. Bandara V, Weinstein SA, White J, Eddleston M. A ...
  • 34. Levine M, Nikkanen H, Pallin DJ. The effects of ...
  • 35. Hack JB, Woody JH, Lewis DE, Brewer K, Meggs ...
  • 36. Muller SH, Diaz JH, Kaye AD. Clinical applications of ...
  • 37. Weinberg G. Lipid Rescue Resuscitation from Local Anaesthetic Cardiac ...
  • 38. Yurtlu BS, Özbilgin Ş, Yurtlu DA, et al. Intravenous ...
  • 39. Bejarovski NG Lipid Rescue Therapy and High-Dose Insulin Euglycemic ...
  • 40. Mir SA & Rasool R Reversal Of Cardiovascular Toxicity ...
  • 41. Mowry JB, Burdmann EA, Anseeuw K, Ayoub P, Ghannoum ...
  • 42. Nissenson AR, Fine RE. Handbook of Dialysis Therapy 5th ...
  • 43. Wang GS, Levitan R, Wiegand TJ, Lowry J, Schult ...
  • 44. Kim Z, Goldfarb D, S: Continuous Renal Replacement Therapy ...
  • 45. Wang GS, Levitan R, Wiegand TJ, Lowry J, Schult ...
  • 46. Lewis, J., Zarate, M., Tran, S Albertson T.The Recommendation ...
  • نمایش کامل مراجع